The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

U. Banerji; D.R. Camidge; H.M.W. Verheul; R. Agarwal; D. Sarker; S.B. Kaye; I.M.E. Desar; J.N.H. Timmer-Bonte; S.G. Eckhardt; K.D. Lewis; K.H. Brown; M.V. Cantarini; C. Morris; S.M.A. George; P.D. Smith; C.M.L. van Herpen

doi:10.1158/1078-0432.CCR-09-2483

The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

U. Banerji, D.R. Camidge, H.M.W. Verheul, R. Agarwal, D. Sarker, S.B. Kaye, I.M.E. Desar, J.N.H. Timmer-Bonte, S.G. Eckhardt, K.D. Lewis, K.H. Brown, M.V. Cantarini, C. Morris, S.M.A. George, P.D. Smith, C.M.L. van Herpen

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1613-1623
Journal	Clinical Cancer Research
Volume	16
Issue number	5
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-2483
Publication status	Published - 2010

Access to Document

10.1158/1078-0432.CCR-09-2483

Cite this

Banerji, U., Camidge, D. R., Verheul, H. M. W., Agarwal, R., Sarker, D., Kaye, S. B., Desar, I. M. E., Timmer-Bonte, J. N. H., Eckhardt, S. G., Lewis, K. D., Brown, K. H., Cantarini, M. V., Morris, C., George, S. M. A., Smith, P. D., & van Herpen, C. M. L. (2010). The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer. Clinical Cancer Research, 16(5), 1613-1623. https://doi.org/10.1158/1078-0432.CCR-09-2483

@article{78be777db2d8429f8a37eafaa8a9c8bb,

title = "The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer",

author = "U. Banerji and D.R. Camidge and H.M.W. Verheul and R. Agarwal and D. Sarker and S.B. Kaye and I.M.E. Desar and J.N.H. Timmer-Bonte and S.G. Eckhardt and K.D. Lewis and K.H. Brown and M.V. Cantarini and C. Morris and S.M.A. George and P.D. Smith and {van Herpen}, C.M.L.",

year = "2010",

doi = "10.1158/1078-0432.CCR-09-2483",

language = "Undefined/Unknown",

volume = "16",

pages = "1613--1623",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

Banerji, U, Camidge, DR, Verheul, HMW, Agarwal, R, Sarker, D, Kaye, SB, Desar, IME, Timmer-Bonte, JNH, Eckhardt, SG, Lewis, KD, Brown, KH, Cantarini, MV, Morris, C, George, SMA, Smith, PD & van Herpen, CML 2010, 'The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer', Clinical Cancer Research, vol. 16, no. 5, pp. 1613-1623. https://doi.org/10.1158/1078-0432.CCR-09-2483

The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer. / Banerji, U.; Camidge, D.R.; Verheul, H.M.W. et al.

In: Clinical Cancer Research, Vol. 16, No. 5, 2010, p. 1613-1623.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

AU - Banerji, U.

AU - Camidge, D.R.

AU - Verheul, H.M.W.

AU - Agarwal, R.

AU - Sarker, D.

AU - Kaye, S.B.

AU - Desar, I.M.E.

AU - Timmer-Bonte, J.N.H.

AU - Eckhardt, S.G.

AU - Lewis, K.D.

AU - Brown, K.H.

AU - Cantarini, M.V.

AU - Morris, C.

AU - George, S.M.A.

AU - Smith, P.D.

AU - van Herpen, C.M.L.

PY - 2010

Y1 - 2010

U2 - 10.1158/1078-0432.CCR-09-2483

DO - 10.1158/1078-0432.CCR-09-2483

M3 - Article

C2 - 20179232

VL - 16

SP - 1613

EP - 1623

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -